Most Trusted
Breast Cancer Resource
Breast Cancer Update

Breast Cancer Update

The Delaware Breast Cancer Coalition's (DBCC) 23rd Annual Breast Cancer Update began as a small scientific meeting to update physicians about the latest trends in breast cancer diagnosis and treatment.

Recognizing the importance of bringing the most up-to-date information to all health professionals, breast cancer survivors, and the general public, the program has grown to an annual conference of more than 430 attendees.

It is our goal to have programming that empowers our community in the fight against breast cancer. The Annual Breast Cancer Update allows us to bring nationally renowned speakers in the breast cancer field and gives us the opportunity to educate the community about the innovative research, treatment, and programs that are available in Delaware.

The 23rd Annual Breast Cancer Update will be held on Wednesday, February 10, 2021, virtually via Zoom from 7:30 a.m. to 2:00 p.m.

Chaired by Marilyn Hyte Planning Committee: Bender, Katelyn Cooke, Vicky Holdridge, Connie Hyte, Marilyn Jessup, Jan Maday, Sally McLaughlin, Mary Murray, Susan Paustian, Kelly Powell, Linda Perdue, Amanda Rothstein, Meridith Vogel, Francesca Wilkinson, Lois Witmer, Dennis Yu, Wilma


2021 OBJECTIVES: 1. Identify recent trends and advances in breast cancer diagnosis, treatment, and clinical trials. 2. Understand protocols and options for the radiologic screening of high-risk patients. 3. Understand the objectives and results of the DBCC “Quality of Life Study”. 4. Understand how tumor profiling and genetic counseling impact treatment options and strategies for patients. 5. Understand integrative medicine i.e. the addition of non-medicinal therapies, and approaches to patient care. As a direct result of the COVID-19 pandemic, the 2020 update was rescheduled from in-person to a virtual format to 2021.

2019 Breast Cancer Update Slides

Carol Tweed - Keynote Advances in the Diagnosis and Treatment of Breast Cancer.pdf

Nanci Mayer Mihalski-Update on DBCC Research Committee Introduction of Research Grant Recipient.pdf

Rishi_Sawhney-Recent Advances in Triple Negative Breast Cancer.pdf

Lisa_Newman-Recent Advances in Triple Negative Breast Cancer.pdf

Margot Savoy- Recent Advances in Triple Negative Breast Cancer.pdf

Wendy Newell-Oncotype Testing.pdf

Adam Raben-Oncotype Testing.pdf

Lauren Mund -Complimentary Therapies-Acupuncture.pdf

Sheri_Jones-Complimentary Therapies-Massage.pdf

Roshni Guerry-Complimentary Therapies-Medical_Marijuana.pdf

2019 Speaker Bios, Agenda and Sponsors!

2019 Pink Packet.pdf

Corexcel is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Certificates of attendance documenting 4 Contact Hours and .4 Continuing Education Units (CEU's) will be available to Nurses and other healthcare professionals.

Corexcel has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, suite 500, McLean, VA 22102. For questions or comments regarding accreditation, please contact Corexcel at .(JavaScript must be enabled to view this email address) or 1-888-658-6641 (M-F, 9am – 5:30pm ET).

To continue to run free and educational breast cancer programs in the community, DBCC relies on donations. To make a donation, click here.

The contents of the Delaware Breast Cancer Coalition (DBCC), such as text, graphics, images, and other material contained on the DBCC Site (“Content”) are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Through this website, you are able to link to other websites which are not under the control of the Delaware Breast Cancer Coalition. We have no control over the nature, content, and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.